Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”
1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9732359
Replication-competent adenoviral vectors
granted -
US 9730941
Methods and compositions for the inhibition of Pin1
granted -
US 9725492
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted -
US 9719080
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted -
US 9717752
Uses of antagonists of hyaluronan signaling
granted -
US 9707220
Scopolamine for the treatment of depression and anxiety
granted -
US 9707230
Activators of human pyruvate kinase
granted -
US 9707287
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
granted -
US 9708267
Activators of human pyruvate kinase
granted -
US 9708392
Monoclonal antibodies against orthopoxviruses
granted -
US 9701718
Adenovirus serotype 26 and serotype 35 filovirus vaccines
granted -
US 9695230
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
granted -
US 9688739
T cell receptors and related materials and methods of use
granted -
US 9683269
Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof
granted -
US 9683263
Detection and treatment of irritable bowel syndrome
granted -
US 9676846
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted -
US 9676771
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
granted -
US 9676857
Soluble engineered monomeric Fc
granted -
US 9670549
Gene expression signatures of neoplasm responsiveness to therapy
granted -
US 9663521
Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis
granted -
US 9663485
Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders
granted -
US 9657066
Pseudomonas exotoxin A with less immunogenic B cell epitopes
granted -
US 9657292
Compositions and methods for treating or preventing lupus
granted -
US 9657269
Regulatory B cells (tBREGS) and their use
granted